Promakhos Therapeutics Inc. — Form D
Promakhos Therapeutics Inc. of SOMMERVILLE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-19. The offering totals $2.2M, of which $2.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-01-19
- Form: D
- Accession: 0001889681-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.2M
- Amount sold: $2.2M
- Investors: 25
- Date of first sale: 2021-03-12
- Revenue range: Decline to Disclose
- SEC file number: 021-429862
Issuer
- Name: Promakhos Therapeutics Inc.
- CIK: 0001889681
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 66 HIGHLAND AVENUE, UNIT 3, SOMMERVILLE, MA, 02143
- Phone: 781-300-1772
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| AIKATERINI EDGAR CHATZI | Director | SOMMERVILLE, MA |
| JASPER EDGAR NEGGERS | Director | SOMMERVILLE, MA |
| AIKATERINI EDGAR CHATZI | Executive Officer | SOMMERVILLE, MA |
| JASPER EDGAR NEGGERS | Executive Officer | SOMMERVILLE, MA |
| AIKATERINI EDGAR CHATZI | Promoter | SOMMERVILLE, MA |
More